These final results, together with a past report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,two aid the notion of targeting ACKR3 as a singular strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-relevant disorders.A research study revealed in Anesthesiology